Komori
Share Issuance and Disposal4978ReproCELL IncorporatedMaterials and Chemicals

Notice Regarding Completion of Payment for the Issuance of New Shares and the 19th Stock Acquisition Rights by Way of the Third Third-Party Allotment under the Share and Stock Acquisition Rights Issuance Program Agreement

Payment for the third-party allotment to CVI Investments, Inc. of 2,932,000 common shares and 29,320 19th Stock Acquisition Rights has been completed.

Worth reading
72In focus
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
2932000
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Issuance of new shares and the 19th Series Stock Acquisition Rights through a third-party allotment

Who receives how much

New shares 2,932,000 shares / Potential shares underlying the stock acquisition rights 2,932,000 shares

CVI Investments, Inc.2,932,000 new shares and 29,320 Stock Acquisition Rights

The lower thin line represents the existing number of shares to which these shares will be added.

New shares: ¥140 per share, Stock Acquisition Rights: ¥140 per right
Total issue value

New shares: ¥410,480,000, Stock Acquisition Rights: ¥4,104,800

Amount of funds to be raised
New shares: ¥410,480,000, Stock Acquisition Rights: ¥549,456,800, assuming all rights are exercised at the initial exercise price
Terms of the stock acquisition rights
Exercise price
Initial exercise price: ¥186 per share. No adjustment to the exercise price. No maximum or minimum exercise price.
Exercise period
Start Date 4 September 2026 / End date 3 September 2030
Number of Stock Acquisition Rights
Total number issued 29,320 rights / Unexercised balance Not disclosed
Payment date
3 September 2026
Details of issuance or disposal
ItemDetails
Type of issuance or disposalIssuance of new shares and the 19th Series Stock Acquisition Rights through a third-party allotment
Number of shares to be issued or disposed ofNew shares 2,932,000 shares / Potential shares underlying the stock acquisition rights 2,932,000 shares
Issue price and disposal priceNew shares: ¥140 per share, Stock Acquisition Rights: ¥140 per right
Total issue valueNew shares: ¥410,480,000, Stock Acquisition Rights: ¥4,104,800
Amount of funds to be raisedNew shares: ¥410,480,000, Stock Acquisition Rights: ¥549,456,800, assuming all rights are exercised at the initial exercise price
Payment date3 September 2026
Intended allotteeName CVI Investments, Inc. / Number of Shares 2,932,000 new shares and 29,320 Stock Acquisition Rights
Exercise priceInitial exercise price: ¥186 per share. No adjustment to the exercise price. No maximum or minimum exercise price.
Exercise periodStart Date 4 September 2026 / End date 3 September 2030
Number of Stock Acquisition RightsTotal number issued 29,320 rights / Unexercised balance Not disclosed
Items this document does not state (18)
Estimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The payment procedures for the third issuance under the resolution of the Board of Directors dated 19 August 2026 and the Equity Program Agreement with CVI Investments, Inc. have been completed.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Completion of Payment for the Issuance of New Shares and the 19th Stock Acquisition Rights by Way of the Third Third-Party Allotment under the Share and Stock Acquisition Rights Issuance Program Agreement | ReproCELL Incorporated (4978) timely disclosure | Komori